Friday, 18 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14422
Articles
Company
Medical Device
Peijia Medical Announces First Patient Implant in MonarQ TTVR System Clinical Study
January 30, 2025
Company
Deals
Zhejiang Dian Diagnostics Partners with Chengdu Eastern New Area for IVD Hub
January 30, 2025
Company
Deals
Anyeep Raises RMB 100 Million in Series A Financing for Mass Spectrometry Development
January 30, 2025
Company
Deals
Shanghai Henlius Biotech to Provide R&D Services for COVID-19 Therapy Azvudine
January 30, 2025
Company
Drug
China Resources Double-Crane Gains Approval for Definity in China
January 30, 2025
Company
Deals
XtalPi Partners with CK Life Sciences to Develop AI Cancer Vaccine Platform
January 30, 2025
Company
Drug
Bliss Bio’s BB-1709 Accepted for Review by China’s CDE
January 30, 2025
Company
Deals
Xiling Lab Raises RMB 100 Million for ADC Development and IND Filing
January 30, 2025
Company
Deals
PrimeLink Bio Raises Funds for ADC Development and R&D Expansion
January 30, 2025
Company
Medical Device
AnchorDx’s UriFind Receives Breakthrough Therapy Designation for Urothelial Carcinoma
January 30, 2025
Company
Deals
Visen Pharmaceuticals Files for Hong Kong IPO with Focus on Growth Hormone
January 30, 2025
Company
Drug
Junshi Biosciences Files for UK Approval of PD-1 Inhibitor Tuoyi
January 30, 2025
1
2
…
1,084
1,085
1,086
1,087
1,088
…
1,201
1,202
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?